“A Lot More Asymptomatic Cancer Out There”: Major MCED Trial Hints at Complicated Future
About this episode
The episode discusses the findings of the NHS-Galleri trial and its implications for cancer detection and screening.
The prospective randomized NHS-Galleri multicancer early detection trial didn’t meet its primary endpoint, but it did uncover a lot more early-stage cancers than predicted. Eric Klein, MD, and Robert Figlin, MD, talk about what the data reveal about cancer biology and for screening programs.
More episodes of Oncology News Central Peer-Spectives
- “The Ever-Shifting and Chaotic” State of CLL Care: What New Data Mean for Practice
- How “Drastically Better” Treatments for Some Colorectal Cancers Are Changing Care
Explore listener stats, chart rankings, contacts and more on the Oncology News Central Peer-Spectives podcast page.